Please login to the form below

Not currently logged in
Email:
Password:

drug safety

This page shows the latest drug safety news and features for those working in and with pharma, biotech and healthcare.

Akcea steals march on Alnylam with NICE approval

Akcea steals march on Alnylam with NICE approval

Analysts say Akcea will be wise to offer greater discounts in order to gain market share, especially as its drug carries a safety warning for thrombocytopenia and renal toxicity which its ... NICE’s ruling adds to the good news for Akcea, which in

Latest news

  • J&J’s Invokana first SGLT2 to show kidney disease benefits J&J’s Invokana first SGLT2 to show kidney disease benefits

    The company is looking to reassure doctors and patients about the safety of Invokana, and recently  revealed real-world data that found no amputation risk for the drug - but this safety ... However, the new safety data, coupled with the new phase 3

  • Amgen and UCB’s Evenity finally approved, but with label warnings Amgen and UCB’s Evenity finally approved, but with label warnings

    However, the drug comes with some cardiovascular safety risks, and it is these that have delayed its arrival on the market, and subsequent label warnings are certain to limit its use. ... Evenity also carries a boxed warning on its label, which advises

  • EMA could follow FDA’s Xeljanz blood clot warning EMA could follow FDA’s Xeljanz blood clot warning

    It says it is now actively examining the trial data and working with Pfizer to better understand the safety signal, its impact on patients, and how the drug should be used. ... The agency says it will take appropriate action to ensure patient safety, but

  • Evenity back on track with FDA panel blessing in osteoporosis Evenity back on track with FDA panel blessing in osteoporosis

    While the FDA still has the final say on full approval, the bone-building drug seems to have finally shaken off the cardiovascular safety concerns that caused the agency to reject ... Importantly for Amgen, FDA briefing documents published ahead of the

  • US government shutdown leaves FDA running on empty US government shutdown leaves FDA running on empty

    One action we’ll be taking is to re-allocate user fee money from certain pre-market drug review work to post-market drug safety surveillance,” he said. ... Those working in drug regulation are still able to tap into 2018’s user-fee pot, but others

More from news
Approximately 3 fully matching, plus 393 partially matching documents found.

Latest Intelligence

  • Five questions guiding the way to actual patient-centricity Five questions guiding the way to actual patient-centricity

    We also learned that patients’ trust, encouraged by a better comprehension of our work, has been correlated with better clinical outcomes and features, including drug adherence and reporting of safety concerns. ... 3 Are we ready to offer value (beyond

  • Behaviour change – a missing ingredient? Behaviour change – a missing ingredient?

    It already invests hugely in long-term development programmes to understand drug efficacy and safety; the step required to take the same long-term view on implementing behaviour change programmes is ... If behavioural aspects are investigated and

  • A new era of smart pharma A new era of smart pharma

    Blending Reportum with AI and Robotic tools affords pharma companies the opportunity to transform their end-to-end drug safety processes today. ... Medical adherence is being improved. Drug delivery technology has improved significantly in recent years.

  • Drug safety

  • Healthcare Glossary

    Search and browse hundreds of industry specific terms and phrases or suggest your own terms and definitions. A graphic element, usually consisting of a symbol and/or group of letters that identifies a company or brand, and helps to create an image

More from intelligence
Approximately 0 fully matching, plus 18 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 9 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Videum Health

Videum Health is a premium video platform that offers brands innovative engagement strategies to reach targeted healthcare audiences on a...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics